AEON · AEON Biopharma, Inc. · Documents
$0.24
+0.01 (+4.10%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these conditions, management has concluded that substantial doubt about our ability to continue as a going concern exists as conditions and events, considered in the aggregate, indicate that it is probable that we will be unable to meet our obligations as they become due within one year after the date that the financial statements included in this Report are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$11.80M
Shares
49.88M
Volume · Oct 20
310.15K
Avg daily vol (3M)
7.53M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2022-08-12 | 2022-06-30 | |
| 10-Q | — | 2022-05-12 | 2022-03-31 | |
| 10-K | — | 2022-03-28 | 2021-12-31 | |
| 10-Q/A | — | 2022-03-03 | 2021-03-31 | |
| 10-Q/A | — | 2022-03-03 | 2021-06-30 | |
| 10-Q/A | — | 2022-03-03 | 2021-09-30 | |
| 8-K/A | — | 2022-03-03 | 2021-02-11 | |
| 8-K | — | 2022-02-25 | 2022-02-24 | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K | — | 2021-06-29 | 2021-06-28 | |
| 10-Q | — | 2021-06-15 | 2021-03-31 | |
| 8-K | — | 2021-06-04 | 2021-05-25 | |
| NT 10-Q | — | 2021-05-17 | 2021-03-31 | |
| 10-K | — | 2021-03-31 | 2020-12-31 | |
| 8-K | — | 2021-03-26 | 2021-03-25 | |
| 8-K/A | — | 2021-02-26 | 2021-02-11 | |
| 8-K | — | 2021-02-18 | 2021-02-11 | |
| 8-K | — | 2021-02-12 | 2021-02-08 | |
| S-1/A | — | 2021-01-29 | — | |
| S-1 | — | 2021-01-21 | — |
Showing 151–171 of 171 filings